Aakha Biologics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$600K
- Investors
-
5
Aakha Biologics General Information
Description
Operator of a biotechnology research company intended to develop next-generation immunotherapies for cancer treatment. The company employs several advanced antibody discovery platforms and a synergistic approach to expedite the optimization, development, and production of therapeutic options, enabling scientists and drug developers to create life-saving therapies and progress from concept to investigational new drug-enabling studies.
Contact Information
Website
www.aakha.bioCorporate Office
- 5680 Frisco Square Boulevard
- Suite 2100
- Frisco, TX 75034
- United States
Corporate Office
- 5680 Frisco Square Boulevard
- Suite 2100
- Frisco, TX 75034
- United States
Aakha Biologics Timeline
Aakha Biologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series A) | 05-Aug-2026 | $600K | Completed | Generating Revenue | ||
| 4. Seed Round | 17-Jul-2024 | Completed | Generating Revenue | |||
| 3. Grant | 22-May-2024 | Completed | Generating Revenue | |||
| 2. Grant | 22-May-2024 | $2.55M | $4.8M | Completed | Generating Revenue | |
| 1. Seed Round | 15-Apr-2024 | $4.8M | $4.8M | Completed | Pre-Clinical Trials |
Aakha Biologics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-2 | ||||||||
| Seed-1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Aakha Biologics Patents
Aakha Biologics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024304442-A1 | Mhc class i chain-related protein a (mica)-specific antibodies and uses thereof | Pending | 15-Jun-2023 | ||
| EP-4727976-A2 | Mhc class i chain-related protein a (mica)-specific antibodies and uses thereof | Pending | 15-Jun-2023 | ||
| WO-2024259273-A2 | Mhc class i chain-related protein a (mica)-specific antibodies and uses thereof | Inactive | 15-Jun-2023 | ||
| WO-2024259273-A3 | Mhc class i chain-related protein a (mica)-specific antibodies and uses thereof | Inactive | 15-Jun-2023 | C07K16/2833 |
Aakha Biologics Signals
Aakha Biologics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ACS BrightEdge | Corporate Venture Capital | Minority | ||
| Opus8 | PE/Buyout | Minority | ||
| Cancer Prevention and Research Institute of Texas | Government | |||
| National Cancer Institute | Government | |||
| Alloy Therapeutics | VC-Backed Company | Minority |
Aakha Biologics FAQs
-
When was Aakha Biologics founded?
Aakha Biologics was founded in 2021.
-
Where is Aakha Biologics headquartered?
Aakha Biologics is headquartered in Frisco, TX.
-
What is the size of Aakha Biologics?
Aakha Biologics has 8 total employees.
-
What industry is Aakha Biologics in?
Aakha Biologics’s primary industry is Drug Discovery.
-
Is Aakha Biologics a private or public company?
Aakha Biologics is a Private company.
-
What is Aakha Biologics’s current revenue?
The current revenue for Aakha Biologics is .
-
How much funding has Aakha Biologics raised over time?
Aakha Biologics has raised $6.15M.
-
Who are Aakha Biologics’s investors?
ACS BrightEdge, Opus8, Cancer Prevention and Research Institute of Texas, National Cancer Institute, and Alloy Therapeutics have invested in Aakha Biologics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process